JAK-IN-5
JAK-IN-5 is an inhibitor of JAK extracted from patent US20170121327A1, compound example 283.
Product Specifications
CAS Number
2096999-92-5
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/JAK_inhibitor_1.html
Solubility
10 mM in DMSO
Smiles
CN1CCC(N2CC(N=C(C3=NNC4=C3C=CC(C5=C(CC)C=C(O)C(F)=C5)=C4)N6)=C6CC2)CC1
Molecular Formula
C27H31FN6O
Molecular Weight
474.57
References & Citations
[1]Paul R. Fatheree, et al. JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease. US20170121327A1|[2]Venkat R, et al. Methods of treatment using a jak inhibitor compound. US20180311226.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
